As of the latest Form 4 filed Jun 3, 2026.
What Alnylam Pharmaceuticals Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 150 most recent filings for ALNY.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I Director | SSale | −17.00 | $302.65 | $5.15K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I, Director | SSale | −495.00 | $300.72 | $149K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I, Director | SSale | −1.22K | $299.87 | $366K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I, Director | SSale | −1.18K | $298.91 | $351K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I, Director | SSale | −921.00 | $297.71 | $274K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I, Director | MExercise | +3.83K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | Sigal Charles Elliott Director | AAward | +671.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | SCHULMAN AMY W Director | AAward | +838.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | Reitan Colleen F Director | AAward | +671.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | PYOTT DAVID E I Director | AAward | +671.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | KELLOGG PETER N Director | AAward | +671.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | HAMBURG MARGARET A Director | AAward | +671.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | BRANDICOURT OLIVIER Director | AAward | +671.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | Ausiello Dennis A Director | AAward | +671.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | Arbuckle Stuart A Director | AAward | +671.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-13 | SCHULMAN AMY W Director | MExercise | +11.3K | $70.20 | $790K | No | Form 4 ↗ |
| 2026-04-07 | 2026-04-06 | McLaughlin Melissa Chief Human Resources Officer | SSale | −199.00 | $333.94 | $66.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-06 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −293.00 | $331.89 | $97.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-06 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −829.00 | $330.46 | $274K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-06 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −909.00 | $329.76 | $300K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-06 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −56.00 | $320.14 | $17.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −8.00 | $325.49 | $2.60K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −81.00 | $323.64 | $26.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −245.00 | $322.86 | $79.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −224.00 | $321.64 | $72.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −147.00 | $320.62 | $47.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −86.00 | $319.69 | $27.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −209.00 | $318.47 | $66.6K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −359.00 | $317.44 | $114K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-02 | McLaughlin Melissa, Chief Human Resources Officer | SSale | −265.00 | $316.61 | $83.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | Garg Pushkal EVP Chief R&D | SSale | −500.00 | $326.08 | $163K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | Garg Pushkal, EVP Chief R&D | SSale | −510.00 | $324.59 | $166K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | Garg Pushkal, EVP Chief R&D | SSale | −740.00 | $323.55 | $239K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | Garg Pushkal, EVP Chief R&D | SSale | −654.00 | $322.33 | $211K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | SSale | −153.00 | $326.24 | $49.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −148.00 | $324.60 | $48.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −233.00 | $323.25 | $75.3K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −124.00 | $321.81 | $39.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Garg Pushkal EVP Chief R&D | SSale | −208.00 | $325.67 | $67.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Garg Pushkal, EVP Chief R&D | SSale | −272.00 | $324.88 | $88.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Garg Pushkal, EVP Chief R&D | SSale | −767.00 | $323.84 | $248K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Garg Pushkal, EVP Chief R&D | SSale | −350.00 | $323.01 | $113K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Garg Pushkal, EVP Chief R&D | SSale | −289.00 | $321.82 | $93.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Garg Pushkal, EVP Chief R&D | SSale | −215.00 | $320.81 | $69.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Garg Pushkal, EVP Chief R&D | SSale | −102.00 | $320.01 | $32.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Garg Pushkal, EVP Chief R&D | SSale | −106.00 | $319.03 | $33.8K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Greenstreet Yvonne Chief Executive Officer | SSale | −265.00 | $325.67 | $86.3K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Greenstreet Yvonne, Chief Executive Officer | SSale | −345.00 | $324.88 | $112K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Greenstreet Yvonne, Chief Executive Officer | SSale | −973.00 | $323.84 | $315K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Greenstreet Yvonne, Chief Executive Officer | SSale | −444.00 | $323.01 | $143K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Greenstreet Yvonne, Chief Executive Officer | SSale | −368.00 | $321.82 | $118K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Greenstreet Yvonne, Chief Executive Officer | SSale | −274.00 | $320.81 | $87.9K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Greenstreet Yvonne, Chief Executive Officer | SSale | −129.00 | $320.01 | $41.3K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Greenstreet Yvonne, Chief Executive Officer | SSale | −135.00 | $319.03 | $43.1K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | SSale | −223.00 | $325.67 | $72.6K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −291.00 | $324.88 | $94.5K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −818.00 | $323.84 | $265K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −374.00 | $323.01 | $121K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −309.00 | $321.82 | $99.4K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −230.00 | $320.81 | $73.8K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −109.00 | $320.01 | $34.9K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −114.00 | $319.03 | $36.4K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Tanguler Tolga EVP, Chief Commercial Officer | SSale | −208.00 | $325.67 | $67.7K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −272.00 | $324.88 | $88.4K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −767.00 | $323.84 | $248K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −350.00 | $323.01 | $113K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −289.00 | $321.82 | $93.0K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −215.00 | $320.81 | $69.0K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −102.00 | $320.01 | $32.6K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −106.00 | $319.03 | $33.8K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | SSale | −57.00 | $325.67 | $18.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −75.00 | $324.88 | $24.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −210.00 | $323.84 | $68.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −96.00 | $323.01 | $31.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −79.00 | $321.82 | $25.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −59.00 | $320.81 | $18.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −28.00 | $320.01 | $8.96K | Yes (planned) | Form 4 ↗ |
| 2026-03-06 | 2026-03-04 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −29.00 | $319.03 | $9.25K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Garg Pushkal EVP Chief R&D | SSale | −463.00 | $321.50 | $149K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Garg Pushkal, EVP Chief R&D | SSale | −640.00 | $320.48 | $205K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Garg Pushkal, EVP Chief R&D | SSale | −317.00 | $319.06 | $101K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Garg Pushkal, EVP Chief R&D | SSale | −355.00 | $316.74 | $112K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | SSale | −359.00 | $321.58 | $115K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −722.00 | $320.51 | $231K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −282.00 | $318.62 | $89.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −289.00 | $316.55 | $91.5K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | SSale | −53.00 | $332.64 | $17.6K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −129.00 | $331.93 | $42.8K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −112.00 | $330.85 | $37.1K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −234.00 | $329.71 | $77.2K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −138.00 | $328.71 | $45.4K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −454.00 | $327.67 | $149K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −541.00 | $326.81 | $177K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −356.00 | $325.63 | $116K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −124.00 | $324.65 | $40.3K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | SSale | −65.00 | $323.62 | $21.0K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Poulton Jeffrey V., EVP, Chief Financial Officer | AAward | +4.77K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal EVP Chief R&D | SSale | −42.00 | $332.64 | $14.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −101.00 | $331.93 | $33.5K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −87.00 | $330.85 | $28.8K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −182.00 | $329.71 | $60.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −107.00 | $328.71 | $35.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −353.00 | $327.67 | $116K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −421.00 | $326.81 | $138K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −277.00 | $325.63 | $90.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −97.00 | $324.65 | $31.5K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | SSale | −50.00 | $323.62 | $16.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Garg Pushkal, EVP Chief R&D | AAward | +4.77K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | SSale | −37.00 | $332.64 | $12.3K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −94.00 | $331.93 | $31.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −81.00 | $330.85 | $26.8K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −170.00 | $329.71 | $56.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −100.00 | $328.71 | $32.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −329.00 | $327.67 | $108K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −392.00 | $326.81 | $128K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −258.00 | $325.63 | $84.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −90.00 | $324.65 | $29.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | SSale | −47.00 | $323.62 | $15.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Fitzgerald Kevin Joseph, CSO & EVP, Head of Research | AAward | +3.69K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | SSale | −37.00 | $332.64 | $12.3K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −94.00 | $331.93 | $31.2K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −81.00 | $330.85 | $26.8K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −170.00 | $329.71 | $56.1K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −100.00 | $328.71 | $32.9K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −329.00 | $327.67 | $108K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −392.00 | $326.81 | $128K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −258.00 | $325.63 | $84.0K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −90.00 | $324.65 | $29.2K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | SSale | −47.00 | $323.62 | $15.2K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Tanguler Tolga, EVP, Chief Commercial Officer | AAward | +4.77K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | SUPRAN BRYAN EVP, CLO and Secretary | AAward | +1.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne Chief Executive Officer | SSale | −160.00 | $332.64 | $53.2K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −399.00 | $331.93 | $132K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −346.00 | $330.85 | $114K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −722.00 | $329.71 | $238K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −424.00 | $328.71 | $139K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −1.40K | $327.67 | $458K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −1.67K | $326.81 | $545K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −1.10K | $325.63 | $358K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −382.00 | $324.65 | $124K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | SSale | −200.00 | $323.62 | $64.7K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Greenstreet Yvonne, Chief Executive Officer | AAward | +13.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Greenstreet Yvonne Chief Executive Officer | MExercise | +5.92K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Poulton Jeffrey V. EVP, Chief Financial Officer | MExercise | +1.91K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Tanguler Tolga EVP, Chief Commercial Officer | MExercise | +1.67K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Garg Pushkal EVP Chief R&D | SSale | −140.00 | $334.39 | $46.8K | Yes (planned) | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Garg Pushkal, EVP Chief R&D | SSale | −942.00 | $332.48 | $313K | Yes (planned) | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Garg Pushkal, EVP Chief R&D | SSale | −1.16K | $331.49 | $384K | Yes (planned) | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Garg Pushkal, EVP Chief R&D | SSale | −2.26K | $330.73 | $747K | Yes (planned) | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Garg Pushkal, EVP Chief R&D | SSale | −127.00 | $328.92 | $41.8K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ALNY’s full analysis or the market-wide insider trading feed. The tabs above jump to ALNY’s other SEC data.
Source: SEC Form 4 filings for ALNY, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.